Literature DB >> 969565

Studies on the metabolism of d-limonene (p-mentha-1,8-diene). IV. Isolation and characterization of new metabolites and species differences in metabolism.

R Kodama, T Yano, K Furukawa, K Noda, H Ide.   

Abstract

1. The main route of elimination of d-limonene administered orally was via the urine in animals and man, 75-95% of the administered radioactivity being excreted in the urine during 2-3 days. Faecal excretion accounted for less than 10% of the dose in animals during 2-3 days. 2. In addition to six metabolites, namely p-mentha-1,8-dien-10-ol (M-I), p-menth-1-ene-8,9-diol (M-II), perillic acid (M-III), perillic acid-8,9-diol (M-IV), p-mentha-1,8-dien-10-yl-beta-D-glucopyranosiduronic acid (M-V) and 8-hydroxy-p-meth-1-en-9-yl-beta-D-glucopyranosiduronic acid (M-VI) isolated from rabbit urine previously (Kodama et al., 1974), five new metabolites have been isolated from dog and rat urine, and which were characterized as 2-hydroxy-p-menth-8-en-7-oic acid (M-VII), perillylglycine (M-VIII), perillyl-beta-D-glucopyranosiduronic acid (M-IX), p-mentha-1,8-dien-6-ol (M-X) and probably p-menth-1-ene-6,8,9-triol (M-XI). 3. The major metabolite of d-limonene in the urine was M-IV in rat and rabbit, M-IX in hamster, M-II in dog and M-VI in guinea pig and man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 969565     DOI: 10.3109/00498257609151649

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  9 in total

1.  The use of d-limonene preparation as a dissolving agent of gallstones.

Authors:  H Igimi; T Hisatsugu; M Nishimura
Journal:  Am J Dig Dis       Date:  1976-11

2.  Limonene in expired lung air of patients with liver disease.

Authors:  M I Friedman; G Preti; R O Deems; L S Friedman; S J Munoz; W C Maddrey
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

3.  Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth.

Authors:  P L Crowell; S Lin; E Vedejs; M N Gould
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Genotoxic and oxidative damage potentials in human lymphocytes after exposure to terpinolene in vitro.

Authors:  Hasan Turkez; Elanur Aydın; Fatime Geyikoglu; Damla Cetin
Journal:  Cytotechnology       Date:  2014-03-04       Impact factor: 2.058

5.  Human metabolism of the experimental cancer therapeutic agent d-limonene.

Authors:  P L Crowell; C E Elson; H H Bailey; A Elegbede; J D Haag; M N Gould
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 6.  The safety evaluation of food flavouring substances: the role of metabolic studies.

Authors:  Robert L Smith; Samuel M Cohen; Shoji Fukushima; Nigel J Gooderham; Stephen S Hecht; F Peter Guengerich; Ivonne M C M Rietjens; Maria Bastaki; Christie L Harman; Margaret M McGowen; Sean V Taylor
Journal:  Toxicol Res (Camb)       Date:  2018-03-28       Impact factor: 3.524

7.  Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications.

Authors:  Bharat Singh; Ram A Sharma
Journal:  3 Biotech       Date:  2014-04-29       Impact factor: 2.406

8.  The metabolomic analysis of five Mentha species: cytotoxicity, anti-Helicobacter assessment, and the development of polymeric micelles for enhancing the anti-Helicobacter activity.

Authors:  Riham O Bakr; Ahmed Tawfike; Heba A El-Gizawy; Nashwa Tawfik; Usama Ramadan Abdelmohsen; Miada F Abdelwahab; Walaa A Alshareef; Sahar M Fayez; Shereen M S El-Mancy; Ahlam M El-Fishawy; Mostafa A Abdelkawy; Marwa A A Fayed
Journal:  RSC Adv       Date:  2021-02-12       Impact factor: 3.361

9.  Histopathological and biochemical assessment of d-limonene-induced liver injury in rats.

Authors:  Carlos Alberto F Ramos; Rita de Cássia da S Sá; Mateus F Alves; Rubens B Benedito; Damião P de Sousa; Margareth de Fátima F M Diniz; Maria Salete T Araújo; Reinaldo N de Almeida
Journal:  Toxicol Rep       Date:  2015-01-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.